Dr. Aran is regarded as a world-renowned expert on autism and cannabinoid research and is credited with conducting pioneering clinical studies on the use of cannabinoid therapeutics in autism. Dr. Aran is well known for his pioneering study on cannabinoids in autistic children. Dr. Aran is regarded as a pioneer in the research of medical cannabis in Autism, a subject that is currently receiving public attention worldwide. About Greater Cannabis Company: The Greater Cannabis Company ( GCAN ), (“GCANRx” or the “Company”) is a fully reporting publicly traded biopharmaceutical company focused on the development of new and effective cannabinoid therapeutics. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release.

Source: CNN December 17, 2021 02:58 UTC